OUR PRODUCTS

Currently approved in Australia

COVID-19 Rapid Test Kits

Corona viruses are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The World Health Organization (WHO) announced that the outbreak of corona virus disease (COVID-19) was first reported from Wuhan, China, on 31 December 2019.

Kodatef

(tafenoquine)

Kodatef is approved for malaria prevention (prophylaxis) when travelling to areas where malaria is present. For information regarding Kodatef, including the Therapeutic Goods Administration (TGA) approved Consumer Medical Information and Product Information (for health professionals only), please click the button below.

‚Äč

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Australian Office: Suite 502, 139 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,

sea and community. We pay our respects to the Elders, past and present. 

Privacy Policy

  • LinkedIn Social Icon